2564 related articles for article (PubMed ID: 1175164)
1. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
Johnson RK; Houchens DP; Gaston MR; Goldin A
Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the immunostimulants levamisole and tetramisole.
Spreafico F; Vecchi A; Mantovani A; Poggi A; Franchi G; Anaclerio A; Garattini S
Eur J Cancer (1965); 1975 Aug; 11(8):555-63. PubMed ID: 1222762
[No Abstract] [Full Text] [Related]
3. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
Chirigos MA; Pearson JW; Pryor J
Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224
[No Abstract] [Full Text] [Related]
5. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Flora KP; van't Riet B; Wampler GL
Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
Stoychkov JN; Miloushev AS
Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
[TBL] [Abstract][Full Text] [Related]
8. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
Johnson RK; Inouye T; Goldin A; Stark GR
Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
[TBL] [Abstract][Full Text] [Related]
10. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B.
Imanishi H; Ohbayashi M; Nishiyama Y; Kawaguchi H
J Antibiot (Tokyo); 1978 Jul; 31(7):667-74. PubMed ID: 80402
[TBL] [Abstract][Full Text] [Related]
11. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Bissery MC; Guénard D; Guéritte-Voegelein F; Lavelle F
Cancer Res; 1991 Sep; 51(18):4845-52. PubMed ID: 1680023
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.
Lasek W; Giermasz A; Kuc K; Wańkowicz A; Feleszko W; Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M
Int J Cancer; 1996 May; 66(3):374-9. PubMed ID: 8621260
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors.
Wodinsky I; Swiniarski JK
Cancer Chemother Rep; 1975; 59(5):939-50. PubMed ID: 1203898
[TBL] [Abstract][Full Text] [Related]
16. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.
Wallace RE; Murdock KC; Angier RB; Durr FE
Cancer Res; 1979 May; 39(5):1570-4. PubMed ID: 427798
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of isomers of 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole.
Hozumi T; Iwaguchi T; Kitagawa H; Ozawa H
Gan; 1978 Jun; 69(3):339-43. PubMed ID: 669135
[TBL] [Abstract][Full Text] [Related]
18. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
Khandalekar DD; Ganu UK; Gokhale SV
Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
[TBL] [Abstract][Full Text] [Related]
19. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systems.
Matuszyk J; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):77-88. PubMed ID: 2619512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]